Portfolio Update

THE THROGMORTON TRUST PLC All information is at 30 June 2009 and unaudited. Performance at month end is calculated on a cum income basis One Three One Three Month Months Year Years Net asset value# 0.2% 22.1% -21.8% -30.6% Net asset value* 0.2% 22.1% -25.6% -33.9% Share price -5.4% 27.6% -29.6% -34.0% HGSC plus AIM (ex Inv Cos) -0.5% 23.8% -24.0% -27.7% # NAV performance prior to costs of repaying the debentures early * NAV performance after costs of repaying the debentures early Sources: BlackRock and Datastream At month end Net asset value Capital only: 111.86p Net asset value incl Income: 115.01p Share price: 92.75p Discount to Capital only NAV: 17.1% Net yield: 2.6% Total assets: £95.3m * Gearing: 0.6% Ordinary shares: 82,351,197 ** * Includes current year revenue. ** Excluding treasury shares. Ten Largest Sector Weightings % of Total Assets Software & Computer Services 11.8 Financial Services 10.8 Support Services 8.4 Oil & Gas Producers 8.1 Mining 5.8 General Retailers 5.0 Industrial Engineering 4.9 Travel & Leisure 4.2 Aerospace & Defence 3.8 Pharmaceuticals & Biotechnology 3.8 ---- Total 66.6 ==== Ten Largest Equity Investments (in alphabetical order) Company Abcam Aveva Group Brewin Dolphin Holdings Dechra Pharmaceuticals Domino Prining Sciences Emerald Energy Fidessa Pace Rathbone Brothers Rensburg Sheppards Commenting on the markets, Mike Prentis and Richard Plackett, representing the Investment Manager noted: During June the NAV increased by 0.2% on a total return basis, whilst the benchmark fell by 0.5%. The FTSE 100 fell by 3.8%. The main contributors to relative outperformance were holdings in Alterian and Domino Printing Sciences. Alterian announced good results and management are confident about prospects. Alterian's analytics software enables organisations to engage with their customers more effectively. Domino Printing delivered very respectable half year results showing earnings down 8%. Domino has cut costs very hard and is well placed to increase profits when markets recover; meanwhile the balance sheet is strong. Relative performance was impacted by a poor contribution from Mouchel Group. Mouchel has failed to win any of the largest contracts it has been tendering for. Whilst it has a large order book of contracted business, it also has a high margin consultancy business where visibility is limited; this seems to have seen a fall off in demand, much of which comes from UK government. Additionally Mouchel has business in the Middle East where it has struggled to get paid. We have met with management to discuss prospects. We see further downside as limited, with the shares trading on less than 7 times current and forecast earnings, but it will take a while for the shares to rerate to previous multiples. Holdings in Chemring, 3i Group and Burberry were sold. We wanted to reduce further our overweight exposure to the aerospace and defence sector as we expect defence budgets to be cut. Much though we like Chemring, and regard executive management highly, we decided to sell the holding. 3i and Burberry shares have both performed strongly since we bought our holdings several months ago. They are quite large companies now in market capitalisation terms, and we are looking for opportunities lower down the size spectrum. We took part in several placings and rights issues, the largest of which were in London West End office investor and developer Great Portland Estates, real estate developer St Modwen Properties, and department store operator Debenhams. We also added holdings in HMV Group and Restaurant Group. In the very short term we see UK consumer stocks and real estate stocks as safer than late cycle industrials. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 16 July 2009
UK 100

Latest directors dealings